Laser treatment for returning high-grade glioma
Part of Cancer clinical trials.
This study tests a laser ablation treatment for people whose high-grade glioma (a fast-growing brain tumor) has come back after standard therapy. The goal is to see if this minimally invasive laser procedure can help control the tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have been diagnosed with a grade 3 or 4 glioma (aggressive brain tumor) and already had standard treatments like radiation or chemotherapy.
- Your tumor must have come back or progressed based on scans or a biopsy.
- All tumor spots must be in the upper part of the brain (above the tentorium) and the largest one must be 30 mm or smaller on an MRI scan.
- You should be well enough to have the procedure, with a Karnofsky score of 60 or higher (meaning you can care for most of your own needs).
- You cannot be pregnant, breastfeeding, or planning pregnancy within 6 months, and must not have a bleeding disorder or be unable to have an MRI with contrast.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called BioTTT001 for people whose high-grade brain tumor has come back after standard treatment. The drug is given through a small device placed in the head to deliver it directly to the tumor area.
This trial tests a radioactive drug that targets a protein on tumor blood vessels to treat glioblastoma that has come back after standard treatment. It may help shrink tumors or slow their growth.
This trial studies a two-step treatment for newly diagnosed high-grade glioma: first laser treatment (LITT) to target the tumor, followed by a shorter, more focused course of radiation. It may help shrink or control the tumor while limiting treatment time.
This trial tests a minimally invasive laser procedure (LITT) to treat glioblastoma that comes back very soon after initial treatment. The goal is to see if laser heat can destroy the tumor before standard radiation and chemotherapy begin, potentially improving outcomes.
This trial tests a minimally invasive laser procedure combined with a new immunotherapy drug (cemiplimab) to treat glioblastoma that has returned after initial treatment. The laser heats and destroys the tumor while the immunotherapy helps your immune system fight remaining cancer cells.
This trial tests a laser treatment called LITT for low-grade glioma (a type of brain tumor) that has come back or is growing despite prior treatment. It aims to see if the laser is safe and effective in young people aged 2 to 25.
Hear when a new Recurrent High Grade Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.